Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Angiopoietins in angiogenesis
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 2833386
Author(s) Fagiani, Ernesta; Christofori, Gerhard
Author(s) at UniBasel Christofori, Gerhard M.
Year 2013
Title Angiopoietins in angiogenesis
Journal Cancer letters
Volume 328
Number 1
Pages / Article-Number 18-26
Keywords Angiogenesis, Angiopoietins, Pericytes, Tie receptors, Tumorigenesis, VEGFA
Abstract Tie-1 and Tie-2 tyrosine kinase receptors are expressed specifically on vascular endothelial cells and on a certain subtype of macrophages implicated in angiogenesis, thus, they have been a major focus of angiogenesis research. Tie-1 and Tie-2 are essential for vascular maturation during developmental, physiological and pathological angiogenesis. Angiopoietin 1-4 (Ang-1-4) have been identified as bona fide ligands of the Tie-2 receptor, while Tie-1 remains an orphan receptor which is able to heterodimerize with Tie-2 and to modulate Tie-2 signal transduction. The most exhaustively studied angiopoietins are Ang-1 and Ang-2. Ang-1 is a critical player in vessel maturation and it mediates migration, adhesion and survival of endothelial cells. Ang-2 disrupts the connections between the endothelium and perivascular cells and promotes cell death and vascular regression. Yet, in conjunction with VEGF, Ang-2 promotes neo-vascularization. Hence, angiopoietins exert crucial roles in the angiogenic switch during tumor progression, and increased expression of Ang-2 relative to Ang-1 in tumors correlates with poor prognosis. Its central role in the regulation of physiological and pathological angiogenesis makes the angiopoietin/Tie signaling pathway a therapeutically attractive target for the treatment of vascular disease and cancer.
Publisher Elsevier
ISSN/ISBN 0304-3835
edoc-URL http://edoc.unibas.ch/dok/A6338675
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.canlet.2012.08.018
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/22922303
ISI-Number WOS:000311661700003
Document type (ISI) Review
 
   

MCSS v5.8 PRO. 0.344 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
24/04/2024